GIST - GASTROINTESTINAL STROMAL TUMOR
Clinical trials for GIST - GASTROINTESTINAL STROMAL TUMOR explained in plain language.
Never miss a new study
Get alerted when new GIST - GASTROINTESTINAL STROMAL TUMOR trials appear
Sign up with your email to follow new studies for GIST - GASTROINTESTINAL STROMAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced GIST: experimental drug NB003 takes on resistant tumors
Disease control Recruiting nowThis study tests an experimental drug called NB003 in people with advanced GIST that has worsened after standard treatments. The trial has two parts: one compares NB003 to the approved drug regorafenib as a third-line therapy, and the other tests NB003 alone as a second-line ther…
Matched conditions: GIST - GASTROINTESTINAL STROMAL TUMOR
Phase: PHASE2, PHASE3 • Sponsor: Ningbo Newbay Technology Development Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for GIST: experimental combo targets hard-to-treat tumors
Disease control Recruiting nowThis study tests whether adding an experimental drug (KQB198) to the standard cancer pill imatinib can shrink or control advanced gastrointestinal stromal tumors (GIST). About 46 adults with a specific gene mutation (KIT or PDGFRA) will receive the combination. The goal is to see…
Matched conditions: GIST - GASTROINTESTINAL STROMAL TUMOR
Phase: PHASE2 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug combo shows promise for Hard-to-Treat stomach cancer
Disease control Recruiting nowThis study tests whether combining two drugs—regorafenib (a targeted therapy) and envafolimab (an immunotherapy)—can help people with advanced GIST that has a specific gene change (KIT exon 17 mutation) and has stopped responding to standard treatments. About 100 adults will be r…
Matched conditions: GIST - GASTROINTESTINAL STROMAL TUMOR
Phase: PHASE2 • Sponsor: Jian Li • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New Two-Tooth clip aims to make stomach tumor removal safer and faster
Symptom relief Recruiting nowThis study tests a new two-tooth clip designed to help doctors remove gastrointestinal stromal tumors (GIST) from the stomach during endoscopy. The clip holds the tumor steady, making it easier to cut away. The trial will compare this method to standard techniques in 60 adults. T…
Matched conditions: GIST - GASTROINTESTINAL STROMAL TUMOR
Phase: NA • Sponsor: Affiliated Hospital to Academy of Military Medical Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC